Ocular pharmacokinetics and availability of topically applied baicalein in rabbits

Current Eye Research

Volumn 34, Issue 4, 2009, Pages 257-263

  Zhang, Li ^a   Zhang, Junjie ^a   Wang, Liya ^a   Xia, Huiyun ^a  

^a Henan Eye Institute   (China)

Author keywords

Aqueous humor; Baicalein; Cornea; Hydroxypropyl beta cyclodextrin; Ocular pharmacokinetics; Rabbit

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; BAICALEIN; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; EXCIPIENT; EYE DROPS; FLAVANONE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; CLINICAL EVALUATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORNEA; DRUG ANALYSIS; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RABBIT; SINGLE DRUG DOSE; SUSPENSION; ANIMAL; EYE; METABOLISM; OSMOLARITY; SOLUBILITY; SOLUTION AND SOLUBILITY; TIME; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANIMALS; AQUEOUS HUMOR; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORNEA; EXCIPIENTS; EYE; FLAVANONES; MALE; OPHTHALMIC SOLUTIONS; OSMOLAR CONCENTRATION; RABBITS; SOLUBILITY; SOLUTIONS; SUSPENSIONS; TIME FACTORS;

EID: 67649646694     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.1080/02713680902725962     Document Type: Article

References (20)

1. Hamada H, Hiramatsu M, Edamatsu R, Mori A. Free radical scavenging action of baicalein. Arch Biochem Biophys 1993;306:261-266.
2. Chang WS, Lee YJ, Lu FJ, Chiang HC. Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res 1993;13:2165-2170.
3. Gao Z, Huang K, Yang X, Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from Scutellaria Baicalensis Georgi. Biochim Biophys Acta 1999;1472:643-650.
4. Shieh DE, Liu LT, Lin CC. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res 2000;20:2861-2865.
5. Hanneken A, Lin FF, Johnson J, Maher P. Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Invest Ophthalmol Vis Sci 2006;47:3164-3177.
6. Hurst JS, Bazan HE. The sensitivity of bovine corneal epithelial lyso-PAF acetyltransferase to cyclooxygenase and lipoxygenase inhibitors is independent of arachidonate metabolites. J Ocul Pharmacol Ther 1997;13:415-426.
7. Bazan HEP, Reddy STK, Lin N. Platelet-activating factor antagonists and ocular inflammation. J Ocul Pharmacol 1994;10:319-327.
8. Nagaki Y, Hayasaka S, Zhang XY, Hayasaka Y, Nakamura N, Terasawa K. Effects of topical instillation of traditional herbal medicines, herbal extracts, and their components on prostaglandin E2-induced aqueousflare elevationinpigmented rabbits. Jpn J Ophthalmol 2003;47:249-253.
9. Nagaki Y, Hayasaka S, Kadoi C, Nakamura N, Hayasaka Y. Effects of scutellariae radix extract and its components (baicalein, baicalin, and wogonin) on the experimental elevation of aqueous flare in pigmented rabbits. Jpn J Ophthalmol 2001;45:216-220.
10. Zhang L, Hu YH, Tian YJ, Li SH, Liu YD. Baicalein inhibition of proliferation and migration of human vascular endothelial cells in vitro. Chin J Chronic Dis 2004;3:64-67.
11. Zhang L, Hu YH. Inhibition of baicalein on corneal neovascularization in rabbit. Chin Ophthal Res 2006;24:364-366.
12. Loftsson, T. Järvinen, T. Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev 1999;36:59-79.
13. Challa R, Ahuja A, Ali J, Khar RK. Cyclodextrins in drug delivery: An updated review. AAPS PharmSciTech 2005;6:E329-E357.
14. Liu J, Qiu L, Gao J, Jin Y. Preparation, characterization, and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta- cyclodextrin. Int J Pharm 2006;312:137-143.
15. Taiming L, Xuehua J. Investigation of the absorption mechanisms of baicalin and baicalein in rats. J Pharm Sci 2006;95:1326-1333.
16. Zhang L, Lin G, Zuo Z. High-performance liquid chromatographic method for simultaneous determination of baicalein and baicalein 7-glucuronide in rat plasma. J Pharm Biomed Anal 2004;36:637-641.
17. Usayapant A, Karara AH, Narurkar MM. Effect of 2-hydroxypropyl-beta- cyclodextrin on the ocular absorption of dexamethasone and dexamethasone acetate. Pharm Res 1991;8:1495-1499.
18. Knapp S, Bertelmann E, Hartmann C, Keipert S, Pleyer U. Intraocular availability of topically applied mycophenolate mofetil in rabbits. J Ocul Pharmacol Ther 2003;19:181-192.
19. Tirucherai GS, Mitra AK. Effectofhydroxypropyl beta cyclodex-trin complexation on aqueous solubility, stability, and corneal permeation of acyl ester prodrugs of ganciclovir. AAPS Pharm-SciTech 2003;4:E45.
20. Bary AR, Tucker IG, Davies NM. Considerations in the use of hydroxypropyl-beta-cyclodextrin in the formulation of aqueous ophthalmic solutions of hydrocortisone. Eur J Pharm Biopharm 2000;50:237-244. 21. Siefert B, Pleyer U, Müller M, Hartmann C, Keipert S. Influence of cyclodextrins on the in vitro corneal permeability and in vivo ocular distribution of thalidomide. J Ocul Pharmacol Ther 1999;15:429-438.